Asim Najmi
Overview
Explore the profile of Asim Najmi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhatia S, Jawad M, Chinnam S, Al-Harrasi A, Shah Y, Khan T, et al.
Food Sci Nutr
. 2025 Jan;
13(1):e4688.
PMID: 39867835
The increasing demand for sustainable food packaging has driven the development of films based on biopolymers. However, enhancing their functional properties remains a challenge. In the current study, potato starch-pectin...
2.
Najmi A
Curr Pharm Des
. 2025 Jan;
PMID: 39812054
Aims: This study aims to identify and evaluate promising therapeutic proteins and compounds for breast cancer treatment through a comprehensive database search and molecular docking analysis. Background: Breast cancer (BC),...
3.
Siddique A, Shaheen M, Abbas A, Zaman Y, Bratty M, Najmi A, et al.
Heliyon
. 2024 Dec;
10(23):e40679.
PMID: 39717568
The extensive use of azo dyes in textile and pharmaceutical industries pose significant environmental and health risks. This problem requires to be tackled forthwith through a cheap, environmentally friendly and...
4.
Khanal S, Pillai M, Biswas D, Islam M, Verma R, Kuca K, et al.
EXCLI J
. 2024 Nov;
23:1245-1275.
PMID: 39574968
Bloodborne pathogens (BBPs) pose formidable challenges in the realm of infectious diseases, representing significant risks to both human and animal health worldwide. The review paper provides a thorough examination of...
5.
Bhatia S, Alhadhrami A, Shah Y, Esatbeyoglu T, Koca E, Aydemir L, et al.
Heliyon
. 2024 Sep;
10(17):e36895.
PMID: 39286085
Essential oils are key ingredients in the development of edible films and provide a diverse approach to improving food preservation, as well as sensory qualities. The pectin and kappa-carrageenan composite...
6.
Jayaswal N, Srivastava S, Kumar S, Sridhar S, Khalid A, Najmi A, et al.
Int J Pharm
. 2024 Jun;
662:124403.
PMID: 38944167
Nanotechnology-based drug delivery systems, including siRNA, present an innovative approach to treating breast cancer, which disproportionately affects women. These systems enable personalized and targeted therapies, adept at managing drug resistance...
7.
Rehman Z, Najmi A, Zoghebi K
Biomolecules
. 2024 Jun;
14(6).
PMID: 38927114
Incidences of drug-resistant tuberculosis have become common and are rising at an alarming rate. Aminoacyl t-RNA synthetase has been validated as a newer target against . Leucyl t-RNA synthetase (LeuRS)...
8.
Khuwaja G, Moni S, Alam M, Makeen H, Zafar S, Ashafaq M, et al.
Nanomedicine (Lond)
. 2024 Apr;
19(12):1069-1085.
PMID: 38661738
The study was designed to develop and analyze curcumin nanoparticles. Curcumin nanoparticles were formulated and evaluated. Their efficacy in protecting against brain damage was investigated in a rat model of...
9.
Javed S, Najmi A, Ahsan W, Zoghebi K
Front Immunol
. 2024 Apr;
15:1383456.
PMID: 38660299
The programmed death-1 receptor (PD-1) acts as a T-cell brake, and its interaction with ligand-1 (PD-L-1) interferes with signal transduction of the T-cell receptor. This leads to suppression of T-cell...
10.
Jain N, Tailang M, Thangavel N, Makeen H, Albratty M, Najmi A, et al.
Acta Pharm
. 2024 Mar;
74(1):1-36.
PMID: 38554385
The arrival of comprehensive genome sequencing has accelerated the understanding of genetically aberrant advanced cancers and target identification for possible cancer treatment. Fibroblast growth factor receptor (FGFR) gene alterations are...